CytoDyn CEO Nader Pourhassan's 2022 pay falls 40% to $6M
CytoDyn reports 2022 executive compensation
By ExecPay News
Published: October 26, 2022
CytoDyn reported fiscal year 2022 executive compensation information on October 26, 2022.
In 2022, five CytoDyn executives received on average a compensation package of $2.6M, a 50% decrease compared to previous year.
Average pay of disclosed executives at CytoDyn
Nader Z. Pourhassan, Chief Executive Officer, received $6M in total, which decreased by 40% compared to 2021. 76% of Pourhassan's compensation, or $4.6M, was in option awards. Pourhassan also received $431K in salary and $1M in other compensation.
Scott A. Kelly, Chief Medical Officer, received a compensation package of $2.5M, which decreased by 26% compared to previous year. 76% of the compensation package, or $1.9M, was in option awards.
Chris P. Recknor, Sr. Executive VP of Clinical Operations, earned $1.9M in 2022.
Antonio Migliarese, Chief Financial Officer, received $1.7M in 2022.
Nitya G. Ray, Chief Technology Officer, earned $1M in 2022, a 60% decrease compared to previous year.
CytoDyn's fiscal year ends on May 31.
Related executives
You may also like
Source: SEC filing on October 26, 2022.